Journal Updates

Novel Insights into Contact Dermatitis
eMediNexus, 05 August 2022
#Dermatology
A recent study published in The Journal of Allergy and Clinical Immunology reported on newly identified biomarkers that distinguish irritant and allergic patch test reactions aid ...MORE
673 Views
0 Comments
PPAR-γ agonist to reduce cardiovascular risk in systemic lupus erythematosus (SLE) patients
eMediNexus, 05 August 2022
#Cardiology #Rheumatology
Research published in the Annals of the Rheumatic Diseases showed that Pioglitazone a PPAR-gamma agonist lowered cardiovascular CV risk in persons with systemic lupus erythematosus S ...MORE
526 Views
0 Comments
Comparison of Dapagliflozin and Empagliflozin’s Long-Term Effectiveness and Safety as Add-On Therapies to Hypoglycemic Drugs in Patients with Type 2 Diabetes
eMediNexus, 30 July 2022
#Cardiology
Type 2 Diabetes is a long-term progressive disease that requires long-term treatment In the real world SGLT2 inhibitors have become commonly used drugs that have demonstrated their abil ...MORE
567 Views
0 Comments
Analysis from the DECLARE-TIMI 58 Study on the Efficacy and Safety of Dapagliflozin in the Elderly
eMediNexus, 30 July 2022
#Cardiology
Due to the high percentages of concurrent comorbidities functional disability frailty cognitive impairment and polypharmacy diabetes management for the elderly is difficult Thus whi ...MORE
681 Views
0 Comments
Sodium-glucose cotransporter 2 inhibitors' current use in type 2 diabetes mellitus treatment
eMediNexus, 30 July 2022
#Cardiology
Type 2 diabetes mellitus T2DM is a chronic and complex metabolic disease characterized by chronic hyperglycemia due to insufficient insulin signaling due to defective insulin secretion a ...MORE
639 Views
1 Comments
Atypical and Rare Forms of Cutaneous Lupus Erythematosus: The Importance of the Diagnosis for the Best Management of Patients
eMediNexus, 29 July 2022
#Dermatology
Lupus erythematosus LE an autoimmune disease shows a wide range of clinical and cutaneous manifestations Besides the well-known typical cutaneous manifestations of LE there are also ...MORE
632 Views
0 Comments
Prev34567Next